Peer Review History

Original SubmissionOctober 3, 2023
Decision Letter - Gianmarco Ferrara, Editor

PONE-D-23-32153Using Implementation Mapping to develop an intervention program to support veterinarians’ adherence to the guideline on Streptococcus suis clinical practice in weaned pigsPLOS ONE

Dear Dr. Speksnijder,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Gianmarco Ferrara, PhD, MVD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

"The VET-ENHANCE project (Veterinary guidelines to support antimicrobial stewardship: enhancing implementation through behavioural interventions) was funded by ZonMw (The Netherlands Organisation for Health Research and Development), project number: 541002005."

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Both reviewers complained about a lack of specificity and concreteness in these guidelines. The authors are requested to improve the manuscript by following the comments listed by the reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is to me an atypical manuscript, since it is more a guide than a scientific paper.

I do not have major comments. I would say that S. suis here seems to be an excuse since most recommendations may be applied to most bacterial infectious diseases...and not specifically for S. suis.

Lines 76-83: I can understand that the previous guide was not followed...and I am not sure this one will be...but it is a good idea to try...

Lines 137-143: it is strange that no expert on S. suis infections has been contacted...it is a highly complicated infection, with no universal markers to identify virulent strains and interventions will be different if a virulent strain is present or not...S. suis may be a primary or a secondary agent.

Lines 147-150: this may be true for infections other than S. suis...

Table 2, 1b: the final diagnostic of a true S. suis infection must be done through the lab...so the word "possible" here is not correct...it should be "mandatory". It is highly necessariy to perform bacterial isolation and serotyping, at minimum.

Table 2, 7: the number of tested piglets should be higher and repeated at least three times in a relatively short period of time: it is not easy to diagnose a S. suis problem and sometimes different serotypes are found in the same herd at the same time, which is an indication of S. suis not being a primary agent...actions to be taken will be different from a herd with the presence of a highly virulent strain...

Table 2, 10: why not arthritis?

Reviewer #2: General comments

The manuscript is well-written and very comprehensive towards the process followed to create and distribute the message on a guideline for Streptococcus suis clinical practice in pigs. Although I can follow the reasoning very closely, I end the review of this manuscript with a lack of ‘what was the final results of these efforts now?’. What I mean is that following the very thorough description of the process gone through to develop the intervention program, the authors state the started implementing the specific groups at the end of the paper, but they do not report any outcome of this large effort made towards the ‘real’ adherence that resulted from the roll-out of the program. Furthermore, I have some more specific comments that need to be addressed.

Specific comments

L83 Please adapt ‘at farms’ by ‘on farms’.

L161 I would rather say ‘In summary, …’ which is more commonly used to come up with a conclusions.

L192 Point 9 of the table. I would prefer to use ‘euthanasia’ instead of the currently used ‘euthanization’ which sounds very unfamiliar to me.

L195 I would exchange ‘holdings’ by ‘farms’.

L392 I presume that ‘imported’ should be ‘important’.

L394 Please correct ‘towards’.

L405 I never heard of the statement ‘In a similar vein, …’. I presume this is a kind of mistake (autosuggestion tool in WORD) and should rather be ‘In a similar way, …’

L406 The sentence ‘For example, our and other results …’ sound a bit weird. Please rephrase in a better readable way.

L410 I have never heard of ‘pigsties’. I presume you mean ‘post-weaning facilities’ which should be a word that all interested readers can understand.

L414 Please write ‘In summary, …’.

L414 The phrase ‘combatting the fight against …’ sound as a double statement. I would suggest to come up with something like ‘In summary, combatting against …’.

L416 Please correct the sentence to ‘The veterinarian has a key role but also functions a a cog in a much bigger machinery.’

L419 Please rephrase ‘… updated and current’ by ‘… updated to the current situation’.

L421 Move ‘also’ from the end of the sentence to ‘… this is also a familiar problem …’.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to Reviewers

PONE-D-23-32153

Using Implementation Mapping to develop an intervention program to support veterinarians’ adherence to the guideline on Streptococcus suis clinical practice in weaned pigs

PLOS ONE

Both reviewers complained about a lack of specificity and concreteness in these guidelines. The authors are requested to improve the manuscript by following the comments listed by the reviewers.

We thank the reviewers for their efforts to review our manuscript and providing valuable feedback for improvements. We have thoroughly read the feedback and recommendations and adapted the manuscript accordingly. We respond to the reviewers’ comments point by point below.

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is to me an atypical manuscript, since it is more a guide than a scientific paper. I do not have major comments. I would say that S. suis here seems to be an excuse since most recommendations may be applied to most bacterial infectious diseases...and not specifically for S. suis.

We thank Reviewer 1 for his/her efforts to review our manuscript and providing feedback for improvements.

This is the first time Implementation Mapping has been used in veterinary medicine to support the implementation of clinical practice guidelines. We used the existing clinical guideline of S. suis as the point of departure for illustrating how Implementation Mapping can be used to develop an intervention to stimulate the implementation of a clinical guideline in practice. While clinical guidelines are widely recognized as valuable components of antimicrobial stewardship programs in veterinary medicine worldwide, a gap exists in understanding how these guidelines can be effectively implemented in veterinary practice. Our aim is to address and fill this knowledge gap which is made more explicit in our manuscript, line 96-99.

Similar papers, in the domain of human medical practice have been published before in PLOS ONE (e.g.: BREATHLEssness in INDIA (BREATHE-INDIA)–Study protocol for the co-design of a community breathlessness intervention in India using realist methods and intervention mapping https://doi.org/10.1371/journal.pone.0293918).

Importantly, we did not develop the clinical guideline for S. suis ourselves. This guideline had been published in 2014 by The Royal Dutch Society of Veterinary Medicine (KNMvD). However, the regular use of the guideline in practice is limited and we aimed to develop an accompanying intervention to support adherence to the veterinary guidelines in practice. The distinction between the existing S. suis guideline and the development of an implementation intervention to support adherence to the guideline is made more explicit in our manuscript, line 20-22, 26-31 and 96-99.

We agree that most recommendations in the S. suis guideline can be applied for most bacterial infectious diseases. Therefore our results are relevant to a broader scope of infections than S. suis alone and the intervention might be used for other infectious diseases. However, we do know that S. suis infections are seen as one of the major drivers of antimicrobial use in the pig sector, and the antimicrobial resistance rates in S. suis have increased worldwide. We describe this also in our introduction in the manuscript, line 70-79.

Lines 76-83: I can understand that the previous guide was not followed...and I am not sure this one will be...but it is a good idea to try...

You are right that the S. suis guideline was used only partly or not at all in practice. We did not make any changes to the guideline itself or develop a new one ourselves, as that is the responsibility of the guideline developer when new scientific or other evidence arises. To make this more clear we made a change, see line 20-22, 26-31 and 96-99. Our aim was to improve adherence to the existing clinical guideline by developing an intervention program to support veterinarians in following the existing guideline. This approach has proved its succes in human medicine, line 107-110.

Lines 137-143: it is strange that no expert on S. suis infections has been contacted...it is a highly complicated infection, with no universal markers to identify virulent strains and interventions will be different if a virulent strain is present or not...S. suis may be a primary or a secondary agent.

We fully agree with this statement about the complexity. The S. suis guideline is indeed developed with experts on S. suis infections from 2012-2014. We made this more explicit, see line 144

Lines 147-150: this may be true for infections other than S. suis...

We do agree that this example can also be used for other infections, but our aim in this study was to critically study barriers for implementation of the S. suis guideline. Our results showed that this example is also the case for S. suis as farmers can have difficulties with giving individual treatments (see also the article: Why Veterinarians (Do Not) Adhere to the Clinical Practice Streptococcus suis in Weaned Pigs Guideline: A Qualitative Study https://doi.org/10.3390/antibiotics12020320). In the introduction we added that the statements in the S. suis guideline are indeed applicable to other infections, lines 81-82.

Table 2, 1b: the final diagnostic of a true S. suis infection must be done through the lab...so the word "possible" here is not correct...it should be "mandatory". It is highly necessariy to perform bacterial isolation and serotyping, at minimum.

The information here describes our performance objective based on what is written in the S. suis guideline, see also our explanation at the first point you raised. Here we want to point out that if bacterial examination or other diagnostics are performed this should be reported. To make this clear we changed the word possible to potential. Table 2.1b Line 198 and in the Supporting Information, S1.1b

Table 2, 7: the number of tested piglets should be higher and repeated at least three times in a relatively short period of time: it is not easy to diagnose a S. suis problem and sometimes different serotypes are found in the same herd at the same time, which is an indication of S. suis not being a primary agent...actions to be taken will be different from a herd with the presence of a highly virulent strain…

Thank you for this recommendation. However, we have not made changes to statements of the S. suis guideline itself. Please also see our earlier explanation that the guideline was already established prior to our work based on a rigorous process involving swine veterinarians and S. suis experts. The focus of our paper is on the development of a strategy to accompany the implementation of the guideline in order to support its adherence.

Table 2, 10: why not arthritis?

The S. suis guideline in the Netherlands is only written for meningitis because of the different treatment plan. This is however outside the scope of our research as we are focused on this existing S. suis guideline, please see also our previous answers.

Reviewer #2: General comments

The manuscript is well-written and very comprehensive towards the process followed to create and distribute the message on a guideline for Streptococcus suis clinical practice in pigs. Although I can follow the reasoning very closely, I end the review of this manuscript with a lack of ‘what was the final results of these efforts now?’. What I mean is that following the very thorough description of the process gone through to develop the intervention program, the authors state the started implementing the specific groups at the end of the paper, but they do not report any outcome of this large effort made towards the ‘real’ adherence that resulted from the roll-out of the program.

We thank Reviewer 2 for his/her efforts to review our manuscript and positive feedback about the reasoning of the process. The final outcome of this article is the intervention program. We do not have the full results of the evaluation of the intervention program trial yet. We aimed to describe the implementation mapping process leading to our outcome, the intervention program. We made this aim more explicit in the introduction, line 96-99. Also to present more clear results, we have added more insights into the actual elements of the intervention program in the article itself by adjusting Table 6, line 309-313.

Furthermore, I have some more specific comments that need to be addressed.

Specific comments

L83 Please adapt ‘at farms’ by ‘on farms’.

We have done so accordingly. Line 86

L161 I would rather say ‘In summary, …’ which is more commonly used to come up with a conclusions.

We have adapted the paper accordingly. Line 167

L192 Point 9 of the table. I would prefer to use ‘euthanasia’ instead of the currently used ‘euthanization’ which sounds very unfamiliar to me.

We have done so accordingly. Line 198 Table 2.9

L195 I would exchange ‘holdings’ by ‘farms’.

We have done so accordingly. Line 200-201

L392 I presume that ‘imported’ should be ‘important’.

We have done accordingly. Line 402

L394 Please correct ‘towards’.

We have done accordingly. Line 404

L405 I never heard of the statement ‘In a similar vein, …’. I presume this is a kind of mistake (autosuggestion tool in WORD) and should rather be ‘In a similar way, …’

"In a similar vein" and "In the same way" convey a similar idea but have slightly different nuances.

"In a similar vein" suggests a similarity or connection in terms of the overall theme or approach, but it doesn't necessarily imply an identical method or process. "In the same way" is more focused on expressing a similarity in the manner or method of doing something. It emphasizes the similarity in the approach or procedure. (https://idioms.thefreedictionary.com/in+a+similar+vein)

We choose to use “in a similar vein”, in consultation with an English native speaker, as this is the nuance we want to give in this sentence.

L406 The sentence ‘For example, our and other results …’ sound a bit weird. Please rephrase in a better readable way.

We have rephrased the sentence. Line 416-417

L410 I have never heard of ‘pigsties’. I presume you mean ‘post-weaning facilities’ which should be a word that all interested readers can understand.

We mean all kind of pig pens and adjusted this. Line 420

L414 Please write ‘In summary, …’.

We have done accordingly. Line 424

L414 The phrase ‘combatting the fight against …’ sound as a double statement. I would suggest to come up with something like ‘In summary, combatting against …’.

We have done accordingly. Line 425

L416 Please correct the sentence to ‘The veterinarian has a key role but also functions a a cog in a much bigger machinery.’

We have done accordingly. Line 426-427

L419 Please rephrase ‘… updated and current’ by ‘… updated to the current situation’.

We have done accordingly. Line 429-430

L421 Move ‘also’ from the end of the sentence to ‘… this is also a familiar problem …’.

Thank you for this recommendation. We have decided to leave the sentence as it is due to its focus on human medicine, as we intended."

Attachments
Attachment
Submitted filename: Response to reviewers_PONE-D-23-32153.docx
Decision Letter - Gianmarco Ferrara, Editor

Using Implementation Mapping to develop an intervention program to support veterinarians’ adherence to the guideline on Streptococcus suis clinical practice in weaned pigs

PONE-D-23-32153R1

Dear Dr. Speksnijder,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gianmarco Ferrara, PhD, MVD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Gianmarco Ferrara, Editor

PONE-D-23-32153R1

PLOS ONE

Dear Dr. Speksnijder,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gianmarco Ferrara

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .